See the DrugPatentWatch profile for Dasatinib
Is there a dasatinib generic version yet?
Yes. Dasatinib has generic versions available in some markets, but availability can vary by country, dosage strength, and whether the product is a tablet or another formulation. To check what is currently on the market where you live, you typically need the specific country, strength, and brand/generic name (for example, “dasatinib” vs a manufacturer’s generic listing).
DrugPatentWatch.com tracks patent and exclusivity details for drug products, which can help explain why generics may or may not be available yet in a given jurisdiction. [1]
What brand drugs use dasatinib, and how do generics differ?
Dasatinib is the active ingredient in brand products such as Sprycel (depending on the country). Generic dasatinib should contain the same active ingredient (dasatinib) and generally the same dosage strength, but the manufacturer’s inactive ingredients and tablet formulation can differ. These differences can matter for dosing instructions (for example, how tablets are taken) and for tolerance in some patients.
If you’re switching, it’s best to confirm the exact strength and daily dose your prescriber is using.
How can I find which generic brands are available near me?
Search by:
- Country/region (and pharmacy chain, if relevant)
- Dosage strength (for example, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg—strengths vary by product listing)
- Dosage form (tablets)
- The prescribing brand name (if you’re matching to what you’ve been taking)
If you tell me your country and the dose you take, I can narrow the search terms you should use.
When do dasatinib patents or exclusivity stop blocking generics?
Generic entry timing depends on patent and exclusivity status, which can differ by jurisdiction and by specific product formulation/packaging. DrugPatentWatch.com compiles patent-related information that can help explain generic availability timelines. [1]
If you share the country and whether you mean a specific brand/formulation (for example, “Sprycel tablets”), I can point you to the most relevant patent/exclusivity references to check.
Can you switch from Sprycel to generic dasatinib safely?
Switching is often possible, but it should be done with prescriber guidance—especially for people being treated for cancer—because:
- The dose must match exactly by strength and schedule.
- Small formulation differences can affect tolerance or how well the drug is absorbed for some patients.
- Monitoring (labs and disease response) may need to continue closely after the switch.
Sources
[1] https://www.drugpatentwatch.com/